These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 317030)
1. Graft rejection, the histocompatibility complex and the Langerhans' cell. Mitchison NA Clin Exp Dermatol; 1979 Dec; 4(4):489-93. PubMed ID: 317030 [No Abstract] [Full Text] [Related]
2. Incomplete tolerance to MHC antigens in irradiation chimeras: implications for MHC restriction and self tolerance. Blanden RV; Ashman RB; O'Neill HC; Woodhams CE; Kees UR; Andrew ME Immunol Rev; 1981; 58():25-36. PubMed ID: 7030923 [No Abstract] [Full Text] [Related]
3. New aspects of Langerhans' cell function. Stingl G Int J Dermatol; 1980 May; 19(4):189-213. PubMed ID: 6772583 [No Abstract] [Full Text] [Related]
4. The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance. Benichou G; Tam RC; Soares LR; Popov IA; Garovoy MR; Fedoseyeva EV Res Immunol; 1996; 147(6):377-87. PubMed ID: 8903104 [No Abstract] [Full Text] [Related]
5. Antigen presentation and allogeneic stimulation by Langerhans cells. Green I; Stingl G; Shevach EM; Katz SI J Invest Dermatol; 1980 Jul; 75(1):44-5. PubMed ID: 6446584 [TBL] [Abstract][Full Text] [Related]
6. Indirect presentation of allogeneic major histocompatibility complex antigens by syngeneic macrophages. Dutta D; Meeusen E; Boyle W Transplant Proc; 1985 Apr; 17(2):1661-3. PubMed ID: 3157249 [No Abstract] [Full Text] [Related]
7. Effect of donor Langerhans cells on corneal graft rejection. Niederkorn JY; Ross JR; He Y J Invest Dermatol; 1992 Nov; 99(5):104S-106S. PubMed ID: 1431197 [TBL] [Abstract][Full Text] [Related]
12. Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. Stingl G; Katz SI; Shevach EM; Rosenthal AS; Green I J Invest Dermatol; 1978 Jul; 71(1):59-64. PubMed ID: 355568 [TBL] [Abstract][Full Text] [Related]
13. Expression of Ia antigens on Langerhans cells in mice, guinea pigs, and man. Rowden G J Invest Dermatol; 1980 Jul; 75(1):22-31. PubMed ID: 6446583 [TBL] [Abstract][Full Text] [Related]
15. Immune responses of thymus/lymphocyte embryonic chimeras: studies on tolerance and major histocompatibility complex restriction in Xenopus. Flajnik MF; Du Pasquier L; Cohen N Eur J Immunol; 1985 Jun; 15(6):540-7. PubMed ID: 3874068 [TBL] [Abstract][Full Text] [Related]
16. Transplants: the reasons for rejection. Clerici E Endeavour; 1985; 9(4):156-60. PubMed ID: 2419109 [No Abstract] [Full Text] [Related]
17. Morphologic studies of acute rat cardiac allograft rejection across an isolated major histocompatibility complex class I (RT1A) disparity. Forbes RD; Lowry RP; Darden AG; Gomersall M; Marghesco DM Transplantation; 1988 May; 45(5):943-8. PubMed ID: 3285541 [TBL] [Abstract][Full Text] [Related]
18. Immunobiology of transplant rejection. Häyry P Ann Clin Res; 1981; 13(4-5):172-98. PubMed ID: 7039479 [No Abstract] [Full Text] [Related]
19. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens. Halliday GM; Odling KA; Muller HK Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936 [TBL] [Abstract][Full Text] [Related]
20. Epidermal Langerhans cells are derived from cells originating in bone marrow. Katz SI; Tamaki K; Sachs DH Nature; 1979 Nov; 282(5736):324-6. PubMed ID: 503208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]